Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Finance > EU weighs curbs on Chinese medical device makers in public bids
    Finance

    EU weighs curbs on Chinese medical device makers in public bids

    Published by Global Banking & Finance Review®

    Posted on January 14, 2025

    2 min read

    Last updated: January 27, 2026

    An image depicting EU officials in a meeting regarding potential curbs on Chinese medical device makers in public tenders, highlighting trade tensions and procurement policies.
    EU officials discussing restrictions on Chinese medical device manufacturers - Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Quick Summary

    The EU may limit Chinese medical device makers in public bids due to unfair practices, aiming for fair market access.

    EU Considers Restrictions on Chinese Medical Device Makers

    By Philip Blenkinsop

    BRUSSELS (Reuters) -EU medical device suppliers are not given fair access to China's public tenders, the European Commission concluded on Tuesday, a finding that could lead to restrictions on Chinese suppliers in Europe.

    The EU executive said it could exclude Chinese bidders from EU public procurement markets or attach a penalty score to their bids for five years to tackle what it described as discrimination.

    The Commission launched its first ever investigation in April 2024 under its International Procurement Instrument, which aims to ensure reciprocity.

    The Commission said it had since found "clear evidence" that China had measures and practices favouring Chinese devices for hospitals and conditions in tenders leading to abnormally low bids that profit-oriented companies could not offer.

    Beijing criticised the investigation's launch at the time and the report is likely to increase tensions. China's commerce ministry said last week that EU investigations into Chinese firms, notably those that manufacture electric vehicles, constituted unfair trade.

    Chinese President Xi Jinping told European Council President Antonio Costa in a phone call on Tuesday he hoped the European Union could become a "a trustworthy partner for cooperation".

    The Commission said the European Union was committed to engaging with China to end the discrimination, but if no acceptable solution was found, it could adopt corrective measures.

    "If it finds that such measures are in the EU interest, they could include a restriction on, or exclusion of, Chinese bidders of government contracts in the EU," the Commission said.  

    The Commission has previously said discussions with China on medical devices had been "fruitless".

    (Reporting by Philip Blenkinsop and Bart MeijerEditing by Christina Fincher)

    Key Takeaways

    • •EU finds unfair access for its medical suppliers in China.
    • •Potential restrictions on Chinese bidders in EU markets.
    • •Investigation under International Procurement Instrument.
    • •China criticized the EU's investigation as unfair.
    • •EU seeks dialogue with China to resolve discrimination.

    Frequently Asked Questions about EU weighs curbs on Chinese medical device makers in public bids

    1What is the main topic?

    The EU is considering restrictions on Chinese medical device makers in public bids due to unfair market practices.

    2Why is the EU investigating Chinese suppliers?

    The EU found evidence of unfair practices and discrimination against EU suppliers in China's public tenders.

    3What could be the outcome of the EU's findings?

    The EU might exclude Chinese bidders or impose penalties on their bids in EU public procurement markets.

    More from Finance

    Explore more articles in the Finance category

    Image for French miner Eramet's finance chief steps aside temporarily, days after CEO ouster
    French miner Eramet's finance chief steps aside temporarily, days after CEO ouster
    Image for Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Image for Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Image for Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Image for Analysis-Glencore to focus on short-term disposals as Rio deal remains elusive
    Analysis-Glencore to focus on short-term disposals as Rio deal remains elusive
    Image for Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut
    Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut
    Image for Big Tech's quarter in four charts: AI splurge and cloud growth
    Big Tech's quarter in four charts: AI splurge and cloud growth
    Image for EU hikes tariffs on Chinese ceramics to 79% to counter dumping 
    EU hikes tariffs on Chinese ceramics to 79% to counter dumping 
    Image for AI trade splinters as investors get more selective
    AI trade splinters as investors get more selective
    Image for EU extends tariff suspension on $109.8 billion of US imports for six months
    EU extends tariff suspension on $109.8 billion of US imports for six months
    Image for Dog food maker Ollie acquired by Spain’s Agrolimen
    Dog food maker Ollie acquired by Spain’s Agrolimen
    Image for Salzgitter to take over HKM steel joint venture, end clash with Thyssenkrupp
    Salzgitter to take over HKM steel joint venture, end clash with Thyssenkrupp
    View All Finance Posts
    Previous Finance PostCzech Republic's need for Russian oil ended by pipeline upgrade
    Next Finance PostGreek PM makes fresh plea to EU to address power price differences